Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 91
Filter
1.
World Neurosurg ; 154: e46-e53, 2021 10.
Article in English | MEDLINE | ID: mdl-34224884

ABSTRACT

OBJECTIVE: Craniopharyngiomas (CPs) are benign, dysontogenetic tumors associated with complex endocrinologic and neurologic symptoms and high morbidity. The aim of this study is to elucidate modifiable effectors of health-related quality of life (HrQoL) of adult patients with CP following neurosurgical intervention using standardized instruments as well as descriptive analysis. METHODS: HrQoL (European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire C30 and BN20) was evaluated in 20 adult patients with CP. We examined pre- as well as postoperative radiologic, hormonal, and symptom-oriented data in a retrospective analysis. Surgical approach, postoperative complications, and extent of resection were recorded. Additional descriptive analysis was performed on case records of all patients with HrQoL results. RESULTS: Long-term follow-up of HrQoL (mean of 75 months) was lower than the in healthy reference group (CP = 58, reference = 75). The most common postoperative complaints were endocrinologic disturbances (88%). Overall, univariate and multivariate logistic regression analysis revealed no significant predictors of reduced postoperative HrQoL. Descriptive analysis did, however, reveal a cluster of patients among those with the lowest global HrQoL which reported new postoperative anosmia and ageusia. CONCLUSIONS: The global HrQoL of our cohort showed a substantial reduction compared with a healthy reference population. Postoperative hyposmia and ageusia is found in patients with the lowest postoperative HrQoL who otherwise had no new significant endocrinologic or neurologic complications. As these symptoms are not regularly accounted for in the HrQoL instruments used in this study, further analysis is needed to determine the possible significance of this complication in CP surgery, and it may affect the choice of surgical approach as well as the information patients receive before consenting to surgery.


Subject(s)
Brain Neoplasms/psychology , Craniopharyngioma/psychology , Quality of Life , Adult , Aged , Ageusia/etiology , Ageusia/psychology , Anosmia/etiology , Anosmia/psychology , Brain Neoplasms/surgery , Craniopharyngioma/surgery , Endocrine System Diseases/etiology , Endocrine System Diseases/psychology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neurosurgical Procedures , Postoperative Complications/epidemiology , Postoperative Complications/psychology , Retrospective Studies , Socioeconomic Factors , Surveys and Questionnaires , Treatment Outcome , Young Adult
2.
Horm Metab Res ; 52(11): 769-774, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32898896

ABSTRACT

The rapid spread of coronavirus disease (COVID-19) worldwide justifies global effort to combat the disease but also the need to review effective preventive strategies and medical management for potentially high-risk populations during the pandemic. Data regarding the COVID-19 manifestations in adults with underlying endocrine conditions, especially diabetes mellitus, are increasingly emerging. Albeit children and adolescents are considered to be affected in a milder manner, paucity of information regarding COVID-19 in children who suffer from endocrinopathies is available. The present review comprehensively collects recommendations issued by various health organizations and endocrine associations for the management of pediatric endocrine conditions during the pandemic. Adhering to the specific "sick day management rules" and undelayed seeking for medical advice are only needed in most of the cases, as the vast majority of children with endocrine disorders do not represent a high-risk population for contamination or severe presentation of COVID-19. Psychological implications in these children and adolescents are also considered.


Subject(s)
Betacoronavirus/physiology , Coronavirus Infections/complications , Endocrine System Diseases/complications , Endocrine System Diseases/virology , Pneumonia, Viral/complications , Adolescent , COVID-19 , Child , Coronavirus Infections/psychology , Endocrine System Diseases/psychology , Humans , Pandemics , Pneumonia, Viral/psychology , SARS-CoV-2
3.
Intern Med ; 59(1): 119-120, 2020 Jan 01.
Article in English | MEDLINE | ID: mdl-31366802

ABSTRACT

Isolated adrenocorticotropic hormone deficiency (IAD) is a cause of adrenal insufficiency (AI), which shows impaired secretion of adrenocorticotropic hormone (ACTH) with the preserved secretion of other anterior pituitary gland hormones. We herein report a case of IAD complicated by chronic thyroiditis presenting with neuropsychiatric symptoms without other signs indicative of AI that showed complete improvement of the cognitive function after the administration of corticosteroids. The clinical features of our case may be confused with autoimmune encephalopathies (AEs); however, IAD should be strictly differentiated from AEs, as it requires permanent hormone replacement without addition of immunosuppressive agents.


Subject(s)
Adrenocorticotropic Hormone/deficiency , Cognitive Dysfunction/diagnosis , Encephalitis/diagnosis , Endocrine System Diseases/diagnosis , Genetic Diseases, Inborn/diagnosis , Hashimoto Disease/diagnosis , Hypoglycemia/diagnosis , Adrenocorticotropic Hormone/metabolism , Autoimmune Diseases/diagnosis , Brain Diseases/diagnosis , Cognitive Dysfunction/etiology , Cognitive Dysfunction/psychology , Diagnosis, Differential , Electroencephalography , Endocrine System Diseases/complications , Endocrine System Diseases/drug therapy , Endocrine System Diseases/psychology , Genetic Diseases, Inborn/complications , Genetic Diseases, Inborn/drug therapy , Genetic Diseases, Inborn/psychology , Hashimoto Disease/complications , Hormone Replacement Therapy , Humans , Hydrocortisone/therapeutic use , Hypoglycemia/complications , Hypoglycemia/drug therapy , Hypoglycemia/psychology , Male , Middle Aged , Thyroiditis/complications
4.
Ann Surg Oncol ; 27(2): 587-596, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31562603

ABSTRACT

BACKGROUND: Total pancreatectomy (TP) is rarely performed due to concerns for endocrine and exocrine insufficiency and decreased quality of life (QoL). Renewed interest is seen in recent years, but large cohort studies remain scarce. This study was designed to evaluate endocrine and exocrine insufficiency after TP and its impact on QoL. METHODS: Adult patients (age ≥ 18 years) who underwent TP between 2008 and 2017 at Karolinska University Hospital with at least 6 months follow-up were included. Endocrine and exocrine insufficiency and QoL were assessed using validated questionnaires (EORTC QLQ-C30, QLQ-PAN26, PAID20, and DTSQs). Both pre- and postoperative questionnaires were available in a subgroup. RESULTS: Of 145 TP, 60 patients were eligible of whom 53 (88.3%) with a median of 21 months (interquartile range [IQR] 13-54) follow-up were included. Symptomatic hypoglycemia occurred in 90.6% (48/53) of patients, and 25% (12/48) experienced ≥ 1 episodes of loss of consciousness. The PAID20 revealed emotional burnout in seven patients (13.2%), whereas a high satisfaction score of diabetes treatment (median 28, IQR 24-32) was measured according to the DTSQs. Overall, 27 patients (50.9%) reported to have steatorrhea during a median of 2 days (IQR 0-4) in the past week. Overall QoL was reduced compared with a general population (66.7% vs. 76.4%; Δ9.7%) but did not differ with preoperative outcomes (n = 39, 66.7%; IQR 41.7-83.3 vs. 66.7%, IQR 50.0-83.3; P = 0.553) according to the EORTC QLQ-C30. CONCLUSIONS: Although the impact of endocrine and exocrine insufficiency on QoL after TP seems acceptable, the management of both insufficiencies should be further improved.


Subject(s)
Diabetes Mellitus/surgery , Endocrine System Diseases/psychology , Exocrine Pancreatic Insufficiency/psychology , Islets of Langerhans/pathology , Pancreatectomy/adverse effects , Pancreatic Neoplasms/surgery , Quality of Life , Adolescent , Adult , Aged , Aged, 80 and over , Cohort Studies , Diabetes Mellitus/pathology , Endocrine System Diseases/etiology , Endocrine System Diseases/pathology , Exocrine Pancreatic Insufficiency/etiology , Exocrine Pancreatic Insufficiency/pathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pancreatic Neoplasms/pathology , Prognosis , Surveys and Questionnaires , Young Adult
5.
J Clin Endocrinol Metab ; 104(11): 5183-5194, 2019 11 01.
Article in English | MEDLINE | ID: mdl-31287545

ABSTRACT

CONTEXT: Childhood cancer survivors experience chronic health conditions that impact health-related quality of life (HRQOL) and participation in optimal physical activity. OBJECTIVE: The study aimed to determine independent effects of endocrine and metabolic disorders on HRQOL and physical activity. DESIGN, SETTING, AND PATIENTS: Retrospective cohort with longitudinal follow-up of survivors of childhood cancer enrolled in the North American Childhood Cancer Survivor Study. MAIN OUTCOME MEASURES: Medical Outcomes Short Form-36 estimated HRQOL, and participation in physical activity was dichotomized as meeting or not meeting recommendations from the Centers for Disease Control and Prevention. Log binomial regression evaluated the association of each endocrine/metabolic disorder with HRQOL scales and physical activity. RESULTS: Of 7287 survivors, with a median age of 32 years (range, 18 to 54 years) at their last follow-up survey, 4884 (67%) reported one or more endocrine/metabolic disorders. Survivors with either disorder were significantly more likely to be male, older, have received radiation treatment, and have experienced other chronic health conditions. After controlling for covariates, survivors with any endocrine/metabolic disorder were more likely to report poor physical function risk ratio (RR, 1.25; 95% CI, 1.05 to 1.48), increased bodily pain (RR, 1.27; 95% CI, 1.12 to 1.44), poor general health (RR, 1.49; 95% CI, 1.32 to 1.68), and lower vitality (RR, 1.21; 95% CI, 1.09 to 1.34) compared with survivors without. The likelihood of meeting recommended physical activity was lower among survivors with growth disorders (RR, 0.90; 95% CI, 0.83 to 0.97), osteoporosis (RR, 0.87; 95% CI, 0.76 to 0.99), and overweight/obesity (RR, 0.92; 95% CI, 0.88 to 0.96). CONCLUSION: Endocrine and metabolic disorders are independently associated with poor HRQOL and suboptimal physical activity among childhood cancer survivors.


Subject(s)
Cancer Survivors/psychology , Endocrine System Diseases/psychology , Exercise , Metabolic Diseases/psychology , Quality of Life , Adult , Endocrine System Diseases/complications , Female , Follow-Up Studies , Humans , Longitudinal Studies , Male , Metabolic Diseases/complications , Neoplasms/complications , Retrospective Studies , Young Adult
6.
Eur J Endocrinol ; 178(5): R155-R181, 2018 May.
Article in English | MEDLINE | ID: mdl-29459441

ABSTRACT

Growth hormone (GH) is produced primarily by anterior pituitary somatotroph cells. Numerous acute human (h) GH treatment and long-term follow-up studies and extensive use of animal models of GH action have shaped the body of GH research over the past 70 years. Work on the GH receptor (R)-knockout (GHRKO) mice and results of studies on GH-resistant Laron Syndrome (LS) patients have helped define many physiological actions of GH including those dealing with metabolism, obesity, cancer, diabetes, cognition and aging/longevity. In this review, we have discussed several issues dealing with these biological effects of GH and attempt to answer the question of whether decreased GH action may be beneficial.


Subject(s)
Endocrine System Diseases/genetics , Endocrine System Diseases/physiopathology , Growth Hormone/physiology , Human Growth Hormone/physiology , Mice, Knockout/genetics , Receptors, Somatotropin/genetics , Animals , Endocrine System Diseases/psychology , Humans , Laron Syndrome/genetics , Laron Syndrome/physiopathology , Longevity , Mice
7.
Article in English | MEDLINE | ID: mdl-29231147

ABSTRACT

BACKGROUND AND OBJECTIVE: Bulimia nervosa, is an eating disorder characterized by excessive influence of weight and body shape on the levels of self-esteem, with pervasive feelings of failure and inadequacy. The eating is characterized by the presence of episodes of uncontrolled eating (Binge), during which the person ingests mass wide variety of foods and the feeling of not being able to stop eating. This review focuses on the metabolic and hormonal alterations in the in bulimia nervosa. METHODS: A literature search was conducted using the electronic database Medline and PubMed and with additional hand searches through the reference list obtained from the articles found. Journal were searched up to 2015. Inclusion criteria were: 1) full text available in English; 2) published in a peerreviewed journal and using the following keywords: neurotransmitters (AgRP, BDNF, αMSH, NP Y, endocannabinoids, adiponectin, CCK, ghrelin, GLP-1, insulin, leptin, PP, PYY), hormones (FSH, LH, estrogen, progesterone, testosterone) and bulimia nervosa, eating disorders. RESULTS: All data reported in the present review indicated that changes in the central and peripheral neuroendocrine equilibria may favor the onset and influence the course and prognosis of a DA. However, it is still questionable whether the alterations of the peptides and hormones regulating the mechanisms of eating behavior are the cause or consequence of a compromised diet. CONCLUSION: The results of the present review indicate that the altered balance of the various peptides or hormones can be relevant not only for the genesis and / or maintenance of altered dietary behaviors, but also for the development of specific psychopathological aspects in eating disorders.


Subject(s)
Bulimia Nervosa/blood , Endocrine System Diseases/blood , Feeding Behavior , Hormones/blood , Metabolic Diseases/blood , Metabolic Diseases/psychology , Neuropeptides/blood , Neurosecretory Systems/metabolism , Biomarkers/blood , Bulimia Nervosa/epidemiology , Bulimia Nervosa/physiopathology , Bulimia Nervosa/psychology , Emotions , Endocrine System Diseases/epidemiology , Endocrine System Diseases/physiopathology , Endocrine System Diseases/psychology , Female , Humans , Male , Metabolic Diseases/epidemiology , Metabolic Diseases/physiopathology , Neurosecretory Systems/physiopathology , Prognosis , Risk Factors , Self Concept
8.
Clin Endocrinol (Oxf) ; 86(6): 772-777, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28370206

ABSTRACT

Consideration of psychological distress in long-term endocrine conditions is of vital importance given the prevalence of anxiety and depression in such disorders. Poor mental health can lead to compromised self-care, higher utilization of health services, lower rates of adherence, reduced quality of life and ultimately poorer outcomes. Adjuvant psychological therapy offers an effective resource to reduce distress in endocrine conditions. While the vast majority of work in this area has focused on psychological screening and intervention in diabetes, identification and recognition of psychological distress are equally important in other endocrinological conditions, with supportive evidence in polycystic ovary syndrome and Addison's disease. Referral pathways and recommendations set out by UK guidelines and the Department of Health mandate requires greater attention across a wider range of long-term endocrine conditions to facilitate improved quality of life and health outcome.


Subject(s)
Endocrine System Diseases/psychology , Endocrine System Diseases/therapy , Psychological Techniques , Addison Disease/psychology , Anxiety Disorders , Depressive Disorder , Endocrine System Diseases/complications , Female , Humans , Male , Polycystic Ovary Syndrome/psychology , Quality of Life , Stress, Psychological/etiology
9.
Eur J Oncol Nurs ; 26: 19-26, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28069148

ABSTRACT

The survival rate after childhood cancer has improved markedly and today more than 80% of patients will survive. Many childhood cancer survivors suffer from late complications due to radiotherapy and chemotherapy. Survivors of Acute Lymphoblastic Leukaemia (ALL), treated with cranial radiotherapy, are at a particularly high risk of having endocrine complications. PURPOSE: To illuminate childhood ALL survivors' experiences of a long-term follow-up in an endocrine clinic. METHOD: Data collection carried out using semi-structured focus-group interviews. Fifteen ALL survivors were included in the study, divided into 4 groups. Data was analysed with conventional qualitative content analysis. RESULTS: The survivors' experiences were captured in the theme: "The need for understanding and support in order to manage daily life". An understanding of their situation, as well as support for managing daily life was fundamental. Lack of understanding and support from the community was connected with a fear for the future. The follow-up at the endocrine clinic was shown to be crucial for increasing the survivors' understanding of late complications. The past feeling of being out of control was replaced with an increased self-confidence. CONCLUSION: Many leukaemia survivors experienced their daily lives as a struggle and as a complicated issue to cope with. The theme "understanding and support to manage daily life" mirrors how the survivors are in need of knowledge and support in order to handle and understand their complex situation after surviving leukaemia. Offering understanding and support with a holistic approach, may be a way in which to strengthen the survivors' health.


Subject(s)
Activities of Daily Living/psychology , Adaptation, Psychological , Endocrine System Diseases/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy , Survivors/psychology , Adolescent , Adult , Child , Child, Preschool , Endocrine System Diseases/psychology , Female , Focus Groups , Follow-Up Studies , Humans , Infant , Longitudinal Studies , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/psychology , Sweden , Young Adult
10.
Brain Behav Immun ; 59: 1-7, 2017 Jan.
Article in English | MEDLINE | ID: mdl-26975888

ABSTRACT

A myriad of factors influence the developmental and aging process and impact health and life span. Mounting evidence indicates that brain injury, even moderate injury, can lead to lifetime of physical and mental health symptoms. Therefore, the purpose of this mini-review is to discuss how recovery from traumatic brain injury (TBI) depends on age-at-injury and how aging with a TBI affects long-term recovery. TBI initiates pathophysiological processes that dismantle circuits in the brain. In response, reparative and restorative processes reorganize circuits to overcome the injury-induced damage. The extent of circuit dismantling and subsequent reorganization depends as much on the initial injury parameters as other contributing factors, such as genetics and age. Age-at-injury influences the way the brain is able to repair itself, as a result of developmental status, extent of cellular senescence, and injury-induced inflammation. Moreover, endocrine dysfunction can occur with TBI. Depending on the age of the individual at the time of injury, endocrine dysfunction may disrupt growth, puberty, influence social behaviors, and possibly alter the inflammatory response. In turn, activation of microglia, the brain's immune cells, after injury may continue to fuel endocrine dysfunction. With age, the immune system develops and microglia become primed to subsequent challenges. Sustained inflammation and microglial activation can continue for weeks to months post-injury. This prolonged inflammation can influence developmental processes, behavioral performance and age-related decline. Overall, brain injury may influence the aging process and expedite glial and neuronal alterations that impact mental health.


Subject(s)
Aging/psychology , Brain Injuries, Traumatic/pathology , Brain Injuries, Traumatic/psychology , Endocrine System Diseases/pathology , Endocrine System Diseases/psychology , Microglia/pathology , Aged , Aged, 80 and over , Animals , Humans , Inflammation/pathology , Inflammation/psychology
11.
BMC Endocr Disord ; 16: 2, 2016 Jan 12.
Article in English | MEDLINE | ID: mdl-26754976

ABSTRACT

BACKGROUND: Isolated adrenocorticotropic hormone (ACTH) deficiency is a pituitary disorder characterized by reduction only in the secretion of ACTH. Although the underlying mechanism remains to be elucidated, numbers of cases with this entity have been increasing. We experienced a case presenting with gait disturbance necessitating differential diagnosis from idiopathic normal pressure hydrocephalus (iNPH). CASE PRESENTATION: A 69-year-old female with a complaint of difficulty walking and suspected to have iNPH at a prior hospital was referred to our department. For the prior three years, she had suffered from a progressive gait disturbance. Magnetic resonance imaging (MRI) revealed global ventricular dilatation. The typical features of the gait in iNPH cases were all identifiable. Neuropsychological dementia scale tests showed deterioration. However, the major feature of a disproportionately enlarged subarachnoid-space on MRI was not obvious. The patient developed progressively worsening fatigue during hospitalization. Her symptoms resembled those of hypothalamic-pituitary tumor patients. Serum ACTH and cortisol levels were low. While corticotrophin releasing hormone stress tests showed no response, other stress tests using thyrotropin releasing hormone, luteinizing hormone releasing hormone, and growth hormone releasing hormone yielded normal responses, indicating a diagnosis of isolated ACTH deficiency. We initiated corticosteroid therapy, and her gait disturbance improved promptly. CONCLUSION: Isolated ACTH deficiency may have major significance to the differential diagnosis of iNPH. Early consideration of this entity is anticipated to facilitate making an early diagnosis.


Subject(s)
Adrenocorticotropic Hormone/deficiency , Endocrine System Diseases/complications , Genetic Diseases, Inborn/complications , Hypoglycemia/complications , Nervous System Diseases/etiology , Aged , Diagnosis, Differential , Endocrine System Diseases/diagnosis , Endocrine System Diseases/psychology , Female , Gait Disorders, Neurologic/diagnosis , Gait Disorders, Neurologic/etiology , Genetic Diseases, Inborn/diagnosis , Genetic Diseases, Inborn/psychology , Humans , Hydrocephalus, Normal Pressure/diagnosis , Hydrocephalus, Normal Pressure/etiology , Hypoglycemia/diagnosis , Hypoglycemia/psychology , Magnetic Resonance Imaging , Nervous System Diseases/diagnosis
12.
Blood Purif ; 41(1-3): 205-10, 2016.
Article in English | MEDLINE | ID: mdl-26765837

ABSTRACT

BACKGROUND: Adolescents and young adults face unique and complex physical, psychological, and family challenges. Despite improvements in care for chronic kidney disease (CKD) and end-stage kidney disease (ESKD), long-term mortality for children, adolescents, and young adults with CKD remains substantially higher than their healthy counterparts. SUMMARY: In this article, we discuss the complex challenges that adolescent and young adult CKD/ESKD patients face. Adolescents have different CKD etiologies and progress along a course dissimilar to the adult population, but have similar multifarious comorbidities. In the setting of puberty and learning to become self-sufficient, adolescence is a critical time for growth and psychosocial development. Physiological complications of CKD underlie many of the long-term outcomes. CKD-mineral and bone disorder and anemia are particularly challenging given that they are exacerbated by the rapid growth of adolescents. Endocrine imbalances and malnutrition can delay and limit growth. All of these factors, together with family dynamics and socioeconomic status, contribute to the poor long-term outcomes and decreased quality of life (QoL) for these patients and their families. KEY MESSAGES: Care for the adolescent CKD/ESKD population is uniquely challenging, but research has identified ways in which we can continue to improve long-term outcomes and QoL for adolescents with CKD/ESKD.


Subject(s)
Anemia/epidemiology , Bone Diseases, Developmental/epidemiology , Cardiovascular Diseases/epidemiology , Endocrine System Diseases/epidemiology , Kidney Failure, Chronic/epidemiology , Renal Insufficiency, Chronic/epidemiology , Adolescent , Anemia/mortality , Anemia/psychology , Anemia/therapy , Bone Diseases, Developmental/mortality , Bone Diseases, Developmental/psychology , Bone Diseases, Developmental/therapy , Cardiovascular Diseases/mortality , Cardiovascular Diseases/psychology , Cardiovascular Diseases/therapy , Child , Comorbidity , Disease Progression , Endocrine System Diseases/mortality , Endocrine System Diseases/psychology , Endocrine System Diseases/therapy , Humans , Kidney Failure, Chronic/mortality , Kidney Failure, Chronic/psychology , Kidney Failure, Chronic/therapy , Quality of Life/psychology , Renal Dialysis , Renal Insufficiency, Chronic/mortality , Renal Insufficiency, Chronic/psychology , Renal Insufficiency, Chronic/therapy , Survival Analysis , Young Adult
13.
Arch Phys Med Rehabil ; 97(2 Suppl): S64-70, 2016 Feb.
Article in English | MEDLINE | ID: mdl-25666783

ABSTRACT

OBJECTIVES: To explore the experiences of women with acquired brain injury (ABI) to gain greater insight into their general and sex- and gender-specific health and well-being concerns, and to identify areas for future research. DESIGN: A qualitative pilot study using interpretive description methodology and a sex-and gender-based analysis of data collected through focus groups. SETTING: Community. PARTICIPANTS: A sample of survivors, and formal and informal caregivers of women with ABI (N=16). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Not applicable. RESULTS: Participants identified significant barriers to achieving optimal health and well-being for women survivors of ABI, including a lack of knowledgeable professionals. We identify 3 interrelated themes: (1) experiences shaped by gender norms and roles; (2) experiences influenced by physiological phenomena, including perceived hormone imbalances; and (3) experiences surrounding interpersonal relationships and sexuality. CONCLUSIONS: Post-ABI care should include education about the influences of sex and gender on health and well-being. Acknowledging the impact of gendered roles, and the broader sociopolitical context of gender and disability, is important to develop appropriate services and supports after ABI. Incorporating effective communication strategies between patient and health care professional can also be a potent rehabilitation strategy.


Subject(s)
Adaptation, Psychological , Brain Injuries/psychology , Health Knowledge, Attitudes, Practice , Survivors/psychology , Adolescent , Adult , Aged , Brain Injuries/rehabilitation , Caregivers/psychology , Endocrine System Diseases/psychology , Female , Focus Groups , Gender Identity , Health Personnel/psychology , Humans , Interpersonal Relations , Middle Aged , Pilot Projects , Qualitative Research , Sexuality/psychology , Young Adult
14.
J R Coll Physicians Edinb ; 45(1): 55-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25874833

ABSTRACT

This review illustrates how an innovative psychoneuroendocrine approach to endocrine patients may improve their management. Important psychological issues pertain to all the different phases of an endocrine disorder. Before disease onset, stressful life events may play a pathogenetic role and, together with chronic stress, may contribute to a cumulative burden also called allostatic load; psychological and psychiatric symptoms are common both in the prodromal and in the active phase of illness; after cure or remission, there could be residual symptoms and impaired quality of life that deserve attention. All these aspects should be taken into consideration and introduced in current endocrine care and practice.


Subject(s)
Endocrine System Diseases/psychology , Anxiety/etiology , Bipolar Disorder/etiology , Depression/etiology , Humans , Morale , Quality of Life , Stress, Psychological/etiology
15.
Can J Diabetes ; 39(4): 325-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25797111

ABSTRACT

The goal of this study was to establish patients' perspectives on the acceptability of wait times, the impact of wait times on their health and the possibility of using electronic consultations (eConsultations) to avoid visits to specialists. A 2-stage patient survey (self-administered and with a follow-up telephone call) and a chart audit was conducted on a sequential sample of patients attending their initial consultations in a tertiary diabetes and endocrinology centre. Patients' perspectives on actual and ideal wait times, the impact of waiting for access, the effectiveness of the referral-consultation process and attitudes toward eConsultations as an alternative to traditional referral-consultations were collected. The study involved 101 patients (22% for diabetes, 78% for endocrinologic conditions), whose comments were collated and categorized. Of the 101 patients who completed the survey, 61 also completed telephone interviews. The average wait time was 19 weeks; the median 10 weeks. More than 30% of patients waited longer than 6 months and 6% waited longer than 1 year. Overall, 90% of patients thought that the maximum wait time should be less than 3 months. While waiting, 58% of patients worried about a serious undiagnosed disease, 30% found their symptoms had affected their daily activities and 24% had to miss work or school due to symptoms. Of the patients, 46% considered eConsultation a viable alternative to face-to-face visits. Excessive wait times for specialist care remain barriers and have negative impacts on patients. Wait times significantly exceeded times patients considered acceptable. eConsultations provide acceptable alternatives for many patients, and they reduced the number of patients requiring traditional consultations.


Subject(s)
Diabetes Mellitus/therapy , Patient Satisfaction , Referral and Consultation/standards , Telemedicine/standards , Tertiary Care Centers/standards , Waiting Lists , Adolescent , Adult , Aged , Aged, 80 and over , Diabetes Mellitus/epidemiology , Diabetes Mellitus/psychology , Endocrine System Diseases/epidemiology , Endocrine System Diseases/psychology , Endocrine System Diseases/therapy , Female , Follow-Up Studies , Health Services Accessibility/standards , Health Services Accessibility/trends , Humans , Male , Middle Aged , Referral and Consultation/trends , Surveys and Questionnaires , Telemedicine/trends , Tertiary Care Centers/trends , Young Adult
16.
J Neurooncol ; 122(1): 169-77, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25582835

ABSTRACT

Pediatric tectal plate gliomas are indolent slow-growing gliomas that often present with increased intracranial pressure or incidentally on routine brain imaging. We investigated clinical outcomes, endocrinopathies, and neuropsychological sequelae associated with tectal plate gliomas. Twenty-six patients with tectal plate glioma were identified in a 20-year retrospective review. Clinical outcomes, treatments, endocrine function, neuropsychological testing outcomes and radiographic imaging were reviewed for possible signs correlating with tumor progression. Among 26 patients, 19 presented with signs or symptoms of increased intracranial pressure (73 %) versus an incidental finding in 7 (27 %). Median follow-up was 46 months (range 8-143 months). Six of 26 (23 %) experienced progressive disease after diagnosis. Five of 26 (19 %) required more than one surgical procedure due to failure of initial endoscopic third ventriculostomy. Seven of 26 had history of endocrine dysfunction, of which, five presented with endocrine dysfunction (precocious puberty or short stature), 1 developed menstrual irregularities after surgical intervention and 1 had preexisting pan hypopituitarism. Of 12 patients with available neuropsychological testing, eleven had at least one indicator of executive functioning in the low-average to impaired range. While tectal plate gliomas have been considered indolent tumors that are rarely progressive, 23 % of patients in our cohort experienced disease progression and required further therapy. Neurocognitive deficits may occur, while endocrine deficiency is uncommon. Regular multidisciplinary oncology follow-up, routine monitoring with MRI and formal neurocognitive evaluation are imperative to provide early recognition of disease progression or recurrent hydrocephalus and to improve school functioning in this population.


Subject(s)
Brain Stem Neoplasms/complications , Endocrine System Diseases/etiology , Glioma/complications , Neurosurgical Procedures/adverse effects , Tectum Mesencephali/pathology , Adolescent , Brain Stem Neoplasms/pathology , Brain Stem Neoplasms/psychology , Brain Stem Neoplasms/surgery , Child , Child, Preschool , Disease Progression , Endocrine System Diseases/diagnosis , Endocrine System Diseases/psychology , Female , Follow-Up Studies , Glioma/pathology , Glioma/psychology , Humans , Infant , Male , Neoplasm Staging , Neuropsychological Tests , Prognosis , Retrospective Studies , Tectum Mesencephali/surgery
17.
Curr Psychiatry Rep ; 17(1): 528, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25413635

ABSTRACT

Cardiovascular and endocrine diseases may act as burdens for individuals suffering from one of these medical illnesses, and whether through the ensuing psychological distress, or some biological mechanisms, these medical diseases can eventually lead to the development of psychiatric morbidities. Moreover, psychiatric morbidities negatively affect the prognosis of both cardiovascular and endocrine diseases. Despite transcultural differences, Egyptian patients with ischemic heart diseases (ISHD), heart failure (HF), diabetes mellitus (DM), or thyroid diseases (TD) endure the same psychological distress as their Western counterparts. Psychiatric assessment and evaluation should be regularly repeated among patients with cardiovascular and endocrinal diseases, and patients who are at risk should be closely followed up.


Subject(s)
Cardiovascular Diseases/complications , Endocrine System Diseases/complications , Mental Disorders/complications , Cardiovascular Diseases/psychology , Egypt , Endocrine System Diseases/psychology , Humans , Mental Disorders/psychology
18.
Riv Psichiatr ; 49(5): 207-16, 2014.
Article in Italian | MEDLINE | ID: mdl-25424334

ABSTRACT

AIMS: This work would give an overall vision of the actual knowledge about nosography and clinic of treatment-resistant depression. METHOD: A PubMed, PsychInfo, Google Scolar search was done using the key words "resistant depression", "STAR*D", "bipolar depression", "staging". Have been selected exclusively works in English, French and Italian languages. RESULTS: Treatment-resistant depression is one of the most important problem in public health. Nevertheless a general consensus about its definition and staging does not exist at now. Principal risk factors and associated comorbidities are well known including the association with bipolar spectrum; anyway the disease particularly common among depressed outpatients is still very disabling, responsible of an often chronic course, with numerous relapses and high risk of suicide. DISCUSSION AND CONCLUSION: The future investigations, once improved procedures for differential diagnosis and subtyping of clinical depression, should be directed to the search of a shared definition of treatment resistance and the development of specific therapeutic protocols.


Subject(s)
Depressive Disorder, Treatment-Resistant , Antidepressive Agents/administration & dosage , Antidepressive Agents/classification , Antidepressive Agents/pharmacokinetics , Antidepressive Agents/therapeutic use , Anxiety Disorders/epidemiology , Biotransformation/genetics , Bipolar Disorder/epidemiology , Bipolar Disorder/psychology , Comorbidity , Depressive Disorder, Treatment-Resistant/classification , Depressive Disorder, Treatment-Resistant/diagnosis , Depressive Disorder, Treatment-Resistant/epidemiology , Depressive Disorder, Treatment-Resistant/therapy , Diagnosis, Differential , Drug Substitution , Electroconvulsive Therapy , Endocrine System Diseases/diagnosis , Endocrine System Diseases/psychology , Genetic Predisposition to Disease , Humans , Models, Psychological , Panic Disorder/epidemiology , Psychotherapy , Recurrence , Risk Factors , Severity of Illness Index , Treatment Failure , Suicide Prevention
20.
Emerg Med Clin North Am ; 32(2): 367-78, 2014 May.
Article in English | MEDLINE | ID: mdl-24766938

ABSTRACT

Although the altered mental status is a common presentation in the emergency department, altered mental status caused by endocrine emergencies is rare. The altered patient could have an endocrine cause that can quickly improve with appropriate diagnosis and interventions. When dealing with limited information and an obtunded patient, it is important to have a broad differential diagnosis, pick up on the physical examination findings, and evaluate laboratory abnormalities that could suggest an underlying endocrine emergency. This article outlines the findings and provides a description of altered patients with endocrine emergencies to facilitate the diagnosis and treatment in the emergency department.


Subject(s)
Emergency Service, Hospital , Endocrine System Diseases , Mental Health , Mental Status Schedule , Emergencies , Endocrine System Diseases/diagnosis , Endocrine System Diseases/psychology , Endocrine System Diseases/therapy , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...